市場調査レポート

商品コード

1510411

不妊治療の市場規模、シェア、成長分析：製品別、処置別、患者タイプ別、エンドユーザー別、地域別 - 産業予測、2024-2031年

Infertility Treatment Market Size, Share, Growth Analysis, By Product(Equipment, Microscopes ), By Procedure(Assisted Reproductive Technology ), By Patient Type, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年07月04日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

不妊治療の2022年の市場規模は32億米ドルであり、予測期間（2024-2031年）のCAGRは6.1%で、2023年の34億米ドルから2031年には54億5,000万米ドルに成長すると予測されています。

不妊治療市場は、不妊率の上昇、妊産婦年齢の上昇、ライフスタイルの変化、医療技術の進歩などさまざまな要因により、最近大きな成長を遂げています。不妊症は世界人口のかなりの部分を占めており、効果的で革新的な治療オプションに対する需要を牽引しています。体外受精（IVF）、卵細胞質内精子注入法（ICSI）、関連処置などの生殖補助医療技術（ART）は、不妊の課題に直面している夫婦にとって主流の選択肢となっています。これらの技術は絶え間ない改良を重ね、より高い成功率と患者の転帰の改善につながっています。不妊治療市場は、これらの技術がより身近で手ごろなものになるにつれて、さらに拡大すると予想されます。技術的進歩に加え、第三者による生殖方法の受け入れ拡大、可処分所得の増加、親になる時期を遅らせる傾向といった要因も市場に影響を与えています。

市場概要
装置
顕微鏡
- イメージングシステム
- 精子分析システム
- 卵子吸引ポンプ
- マイクロマニピュレーターシステム
- インキュベーター
- ガス分析装置
- レーザーシステム
- クライオシステム
- 精子分離システム
メディア・消耗品
付属品

不妊治療市場：処置別

市場概要
生殖補助医療技術（ART）
- 体外受精IVF
- 卵細胞質内精子注入
- 代理出産
人工授精
- 子宮内
- 子宮頸管内
- 卵管内授精
不妊手術
- 腹腔鏡検査
- 子宮鏡検査
- 子宮筋腫摘出術
- 開腹手術
- 卵管結紮解除
- 静脈瘤切除術
- 顕微手術による再建
- 血管造設術
- 精管精巣吻合術
その他

不妊治療市場：患者タイプ別

市場概要
女性
男性

不妊治療市場：エンドユーザー別

市場概要
不妊クリニック
病院
外科センター
クライオバンク
研究機関

不妊治療市場：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Merck KGaA（Germany）
Bayer AG（Germany）
Ferring Pharmaceuticals（Switzerland）
CooperSurgical, Inc.（United States）
Cook Medical（United States）
Vitrolife AB（Sweden）
Irvine Scientific（United States）
Origio（Denmark）
Progyny, Inc.（United States）
OvaScience（United States）
Monash IVF（Australia）
Genea Limited（Australia）
Boston IVF（United States）
Cryo-Save AG（Switzerland）
Invo Bioscience（United States）
Reproductive Medicine Associates of New Jersey（United States）
Virtus Health（Australia）
LifeGlobal Group, LLC（United States）
Andrology Solutions（United States）
ProcreaTec（Spain）

Product Code: SQMIG35D2204

Infertility Treatment Market size was valued at USD 3.2 Billion in 2022 and is poised to grow from USD 3.40 Billion in 2023 to USD 5.45 Billion by 2031, at a CAGR of 6.1% during the forecast period (2024-2031).

The infertility treatments market has seen significant growth recently due to various factors including rising infertility rates, increased maternal age, lifestyle changes, and advancements in medical technology. Infertility affects a substantial portion of the global population, driving the demand for effective and innovative treatment options. Assisted reproductive technology (ART), such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and related procedures, have become mainstream choices for couples facing infertility challenges. These technologies have undergone continuous improvements, leading to higher success rates and improved patient outcomes. The market for infertility treatments is expected to expand further as these technologies become more accessible and affordable. In addition to technological advancements, the market is influenced by factors like increasing acceptance of third-party reproduction methods, rising disposable incomes, and the trend of delaying parenthood.

Top-down and bottom-up approaches were used to estimate and validate the size of the Infertility Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Infertility Treatment Market Segmental Analysis

The global Infertility Treatment market is segmented based on product, patient type, procedure, end-user, and region. Based on Product, the market is segmented into Microscopes, Media & Consumables, Accessories which are which are further categorized. By Procedure, it is divided into Assisted Reproductive Technology (In Vitro Fertilization [Intracytoplasmic Morphologically Selected Sperm Injection, Gamete Donation], Intracytoplasmic Sperm Injection, Surrogacy), Artificial Insemination (Intrauterine, Intracervical, and Intratubal), Fertility Surgeries (Laparoscopy, Hysteroscopy, Myomectomy, Laparotomy, Tubal Ligation Reversal, Varicocelectomy, Microsurgical Reconstruction [Vasovasostomy, Vasoepididymostomy]), Others. Based on patient type, the market is segmented into Female Infertility Treatment, and Male Infertility Treatment. Based on End-User, it is segmented into Fertility Clinics, Hospitals, Surgical Centers, Research Institutes. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.

Drivers of the Infertility Treatment Market

The rise in global infertility rates is attributed to factors such as lifestyle changes, delayed parenthood, and environmental influences. This increase in the number of individuals and couples experiencing fertility challenges has led to a heightened demand for infertility treatment options. Additionally, advancements in medical technology, particularly in assisted reproductive technologies such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), have significantly improved success rates, making these treatments more effective and accessible.

Restraints in the Infertility Treatment Market

One of the primary challenges in the market is the high cost associated with advanced infertility treatments like in vitro fertilization (IVF) and genetic screening. The significant financial burden of these procedures creates a substantial barrier to access for many people. Furthermore, ethical concerns related to assisted reproductive technologies, such as issues surrounding embryo manipulation and the ethical implications of surrogacy, introduce complexities that can hinder market growth.

Market Trends of the Infertility Treatment Market

Increasing consumer awareness and greater adoption of straightforward labeling products: There is a rising trend towards precision medicine approaches, particularly in in vitro fertilization (IVF). Genetic testing and screening technologies have become increasingly essential, enabling more targeted and personalized selection of embryos with higher chances of successful implantation, thereby reducing the risk of genetic disorders. Another significant trend involves the increasing acceptance and integration of third-party reproduction methods. Surrogacy, as well as egg or sperm donation, are gaining wider societal acceptance, offering alternative pathways to parenthood for individuals and couples experiencing infertility challenges.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Ecosystem of the Market
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Infertility Treatment Market by Product

Market Overview
Equipment
Microscopes
- Imaging Systems
- Sperm Analyzer Systems
- Ovum Aspiration Pumps
- Micromanipulator Systems
- Incubators
- Gas Analysers
- Laser Systems
- Cryosystems
- Sperm Separation Systems
Media & Consumables
Accessories

Infertility Treatment Market by Procedure

Market Overview
Assisted Reproductive Technology
- In Vitro Fertilization IVF
- Intracytoplasmic Sperm Injection
- Surrogacy
Artificial Insemination
- Intrauterine
- Intracervical
- Intratubal Insemination
Fertility Surgeries
- Laparoscopy
- Hysteroscopy
- Myomectomy
- Laparotomy
- Tubal Ligation Reversal
- Varicocelectomy
- Microsurgical Reconstruction
- Vasovasostomy
- Vasoepididymostomy
Others

Infertility Treatment Market by Patient Type

Market Overview
Female Infertility Treatment
Male Infertility Treatment

Infertility Treatment Market by End User

Market Overview
Fertility Clinics
Hospitals
Surgical Centres
Cryobanks
Research Institutes

Infertility Treatment Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring Pharmaceuticals (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperSurgical, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitrolife AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Irvine Scientific (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Origio (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Progyny, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OvaScience (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Monash IVF (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genea Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston IVF (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cryo-Save AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invo Bioscience (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Reproductive Medicine Associates of New Jersey (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Virtus Health (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LifeGlobal Group, LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Andrology Solutions (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ProcreaTec (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments